NEELIE WILLIS: Open Payments
NPI 1477590958 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 30 payments from 8 companies in 2025. Trend: 2023 $385 · 2024 $476 · 2025 $644
Food & beverage: $545Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $188 |
| Novartis Pharmaceuticals Corporation | 7 | $145 |
| ABBVIE INC. | 4 | $101 |
| Amgen Inc. | 1 | $73 |
| Organon LLC | 7 | $71 |
| Galderma Laboratories, L.P. | 2 | $31 |
| UCB, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, SKYRIZI, Otezla, VTAMA, Rhapsido, COSENTYX, NEMLUVIO, RINVOQ.
Industry payments across ID — which companies pay providers there.
